CNTN
Tharimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.30
+2.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 30.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.40x
- Price / sales
- 122.25x
- Price / cash flow
- -8.25x
Enterprise value
- Enterprise value
- $145.6M
- EV / sales
- 97.35x
- EV / EBITDA
- -1.66x
- EV / EBIT
- -2.71x
- Market cap
- $182.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026